Pure Global
NCT04865081

Clinical Evaluation of an Aerosol Protective Intubation Device on Videolaryngoscopic Intubation Difficulty

First Randomised Controlled Clinical Evaluation of the Impact of Anti-Aerosol VACCIN Box on the Videolaryngoscopic Intubation Procedure
Maisonneuve-Rosemont Hospital·ClinicalTrials.gov·device·Device trial
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intubation
Drug/Device/Intervention
VACCIN box
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Maisonneuve-Rosemont Hospital
Location
Montreal, Canada
Timeline & enrollment
Phase
N/A
Start date
Apr 19, 2021
End date
Jul 01, 2021
Enrollment
60 participants
Primary outcome

Intubation time

Summary

The VACCIN box, an anti-aerosol intubation box for potential use on COVID-19 (SARS-CoV-2)
 positive patients, was designed in order to reduce the transmission risk to healthcare
 workers. This study will compare the safety and the ease of use of the VACCIN box to a
 standard intubation in healthy participants undergoing elective surgery. It is expected that
 intubation times and success rate of intubation in the same circumstances will be similar
 with and without the use of the VACCIN box.

ICD-10 classifications
Failed or difficult intubationFailed or difficult intubation during labour and deliveryFailed or difficult intubation during pregnancyFailed or difficult intubation during the puerperiumRespiratory arrest
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04865081
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04865081 through Pure Global AI's free database. This phase not specified trial is sponsored by Maisonneuve-Rosemont Hospital and is currently status unknown. The study focuses on Intubation. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.